Nasonov_E.L._Антифосфолипидный синдром_(Literra,2004)-1

151.Espinosa G, Cervera R, Font J, Asherson RA. The lung in the antiphospholipid syndrome Ann Rheum Dis. 2002; 61: 195—198.

152.Asherson RA, Cervera R. Review: anti phospholipid antibodies and the lung. J Rheu matology 1995; 22: 62—66.

153.Luchi ME, Asherson RA, Lahita RG. Primary idiopathic pulmonary hypertension com plicated by pulmonary arterial thrombosis: Association with antiphospholipid antibodies. Arthritis Rheum 1992; 35: 700—705.

154.Asherson RA, Oakley CN. Pulmonary hypertension and systemic lupus erythematosus. J Rheumatol 1986; 13: 1—5.

155.Ghosh S, Walters HD, Joist JH, Osborn TG, Moore TL. Adult respiratory distress syn drome associated with antiphospholipid anti body syndrome. J Rheumatol 1993; 20: 1406— 1408.

156.Howe HS, Boey ML, Fong KY, Feng PH. Pulmonary haemorrhage, pulmonary infarction and the lupus anticoagulant. Ann Rheum Dis 1988; 47: 869—872.

157.Maggiorine M, Knoblauch A, Schneider J, et al. Diffuse microvascular pulmonary thrombo sis in primary antiphospholipid syndrome. Eur Resp J 1997; 10: 727—730.

158.Gertner E, Lie JT. Pulmonary capillaritis, alveolar haemorrhage and recurrent microvascu lar thrombosis in primary antiphospholipid syn drome. J Rheumatol 1993; 20: 1224—1228.

159.Savin H, Huberman M, Koh E, et al. Fibrosing alveolitis associated with primary antiphospholipid syndrome. Br J Rheumatology 1994; 33: 977—980.

160.Brucato A, Baudo F, Barberis M. et al. Pulmonary hypertension secondary to thrombosis of the pulmonary vessels in a patient with the pri mary antiphospholipid syndrome. J Rheumatol 1994; 2: 942—944.

161.Turijansku AA, Finkielman JD, Vazquez Blanco. Isolated tricuspidal valve disease in antiphospholipid syndrome. Lupus 1998; 8: 474— 476.

162.Moser KM, Auger WR, Fedullo PF. Chronic major vessel thromboembolic pulmonary hypertension. Circulation 1990; 81: 1735—1743.

163.Jamieson SW, Auger WR, Fedullo PF, et al. Experience and results with 150 pulmonary

thromboendarterectomy operations over a 29 month period. J Thorac Cardiovascular Surg 1993; 106: 116—127.

164.Sandaval J, Amigo MC, Barragan R, et al. Primary antiphospholipid syndrome presenting as chronic thromboembolic hypertension. Treatment with Thromoendarterctomy. J Rheumatol 1996;

23:772—775.

165.Crausman RS, Achenbach GA, Pluss WT, et al. Pulmonary capillaritis and alveolar haem orrhage associated with the antiphospholipid syn drome. J Rheumatol 1995; 22: 554—556.

166.Schwab EP, Schumacher HR, Freundlich B, Callegari PE. Pulmonary alveolar haemor rhage in systemic lupus erythematosus. Semin Arthritis Rheum 1993; 23: 8—15.

167.Hillerdal G, Hagg A, Licke G, Wegenius G, Scheibenflug L. Intraalveolar haemorrhage in the anticardiolipin antibody syndrome. Scand J Rheumatol 1991; 20: 58—62.

168.Kelion AD, Cockroft JR, Ritter JM. Anti phospholipid syndrome in a patient with rapidly progressive fibrosing alveolitis. Postgrad Med J 1994; 71: 233—235.

169.Branch DW, Kochenour NP, Rote NS, et al. New post partum syndrome associated with antiphospholipid antibodies. Obstet Gynecol 1987; 69: 460—468.

170.Kerr JE, Poe R, Kramer Z. Antiphos pholipid antibody syndrome presenting as a refractory non inflammatory pulmonary vascu lopathy. Chest 1997; 112: 1707—1710.

171.Asherson RA, Hughes GRV. Hypoadre nalism, Addison's disease and antiphospholipid antibodies. J Rheumatol 1991; 18: 1—3.

172.Asherson RA. Hypoadrenalism and the antiphospholipid antibodies. A new cause of idio pathic "Addison's disease". In: Bhatt, James, Besser, Botazzo, Keen (eds): Advances in Thomas Addison's diseases. Vol. 1. J Endocrinol Ltd. Bristol. 1994; 87—101.

173.Arnason JA, Graziano FM. Adrenal insuffi ciency in the antiphospholipid antibody syndrome. Semin Arthritis Rheum 1995; 25: 109—116.

174.Pelkonen P, Simell O, Rasi V, et al. Venous thrombosis associated with the lupus anti coagulant. Ann Intern Med 1980; 92: 156—159.

175.Grottolo A, Ferrari V, Mariarosa M, et al. Primary adrenal insufficiency, circulating Lupus

Насонов Е.Л. Антифосфолипидный синдром

Anticoagulant and anticardiolipin antibodies in a patient with multiple abortions and recurrent thrombotic episodes. Haematologia 1988; 73: 517—519.

176.Asherson RA, Hughes GRV. Recurrent deep vein thrombosis in Addison's disease in "primary" antiphospholipid syndrome. J Rheumatol 1989; 16: 378—380. Carette S, Jobin F. Acute adrenal insuf ficiency as a manifestation of the anticardiolipin syndrome. Ann Rheum Dis 1989; 48: 430—431.

177.Rao R, Vagnucci A, Amico J. Bilateral mas sive adrenal haemorrhage: Early recognition and treatment. Ann Intern Med 1989; 110: 227—235.

178.Marie I, Levesque H, Heron F, Kailleux N, Borg JY, Courtois H. Acute adrenal failure secondary to bilateral infarction of the adrenal glands as the first manifestation of primary antiphospholipid antibody syndrome. Ann Rheum Dis 1997; 567—568.

179.Argento A, Di Benedetto RJ. ARDS and adrenal insufficiency associated with the antiphospholipid antibody syndrome. Chest 1998;

113:1136—1138.

180.Guibal F, Rybojad M, Cordoliani F, et al. Melanoderma revealing primary antiphospholipid syndrome. Dermatol 1996; 192: 75—77.

181.Provenzale JM, Ortel TL, Nelson RC. Adrenal haemorrhages in patients with primary antiphospholipid syndrome: Imaging findings. Am J Roentgenol 1995; 165: 361—364.

182.Oelkers W. Adrenal insufficiency IV. N Engl J Med 1996; 335: 1206—1212.

183.Pomeroy C, Knodell RG, Swain WR, Arneson P, Mahowald ML. Budd Chiari syn drome in a patient with the lupus anticoagulant. Gastroenterology 1984; 86: 158—161.

184.Shimizu S, Miyata M, Kamiike W, et al. Budd Chiari syndrome combined with antiphos pholipid syndrome: Case report and literature review. Vasc Surg 1993; 501—509.

185.Farrant JM, Judge M, Thompson RDH. Thrombotic cutaneous nodules and hepatic vein thrombosis in the anticardiolipin syndrome. Clin Exp Dermatol 1989; 14: 306—308.

186.Ouwendijk RJT, Koster JC, Wilson JHP, et al. Budd Chiari syndrome in a young patient with anticardiolipin antibodies: Need for pro longed anticoagulant treatment. Gut 1994; 35: 1004—1006.

187.Mackworth Young CG, Gharavi AE, Boey ML, Hughes GRV. Portal and pulmonary hyper tension in a case of systemic lupus erythematosus: Possible relationship with a clotting abnormality. Eur J Rheum Inflam 1984; 7: 71—74.

188.Ordi J, Vargas V, Vilardell M, et al. Lupus anticoagulant and portal hypertension. Am J Med 1988; 84: 566—568.

189.De Clerck L, Michielsen PP, Ramael MR, et al. Portal and pulmonary vessel thrombosis associated with systemic lupus erythematosus and anticardiolipin antibodies. J Rheumatol 1991; 18: 1919—1921.

190.Takahaski C, Kumagai S, Tsubata R, et al. Portal hypertension associated with anticardi olipin antibodies in case of systemic lupus eErythematosus. Lupus 1995; 4: 232—235.

191.Mantz FA, Craige E. Portal axis thrombo sis with spontaneous portacaval shunt and result ant cor pulmonale. Arch Pathol 1951; 52: 91—97.

192.Nakamura H, Uehara H, Okada T, et al. Occlusion of small hepatic veins associated with systemic lupus erythematosus with the lupus anti coagulant. Hepatogastroenterol 1989; 36: 393— 397.

193.Morio S, Oh H, Hirasawa A, et al. Hepatic veno occlusive disease in a patient with lupus anticoagulant after allogeneic bone marrow transplantation. Bone Marrow Transplant 1991;

8:147—149.

194.Morle RM, Ramos Casals M, Garcia Carrasco M, et al. Nodular regenerative hyper plasia of the liver and antiphospholipid antibod ies: report of two cases and review of the literature. Lupus 1999; 8: 160—163.

195.Rio B, Andreu G, Nicod A, et al. Thrombocytopenia in veno occlusive disease after bone marrow transplantation or chemotherapy. Blood 1986; 67: 1773—1776.

196.Perez—Ruiz F, Orte Martinez FJ, Zea Mendoza AC, Ruiz del Arbol L, Moreno Caparras A. Nodular regenerative hyperplasia of the liver in rheumatic diseases: report of seven cases and review of the literature. Semin Arthritis Rheum 1991; 21: 47—54.

197.Mor T, Beigel Y, Inbal A, Goren M, Wysenbeek A G. Hepatic infarction in a patient with the lupus anticoagulant. Arthritis Rheum 1989; 32: 491—495.

198.Kinoshita K. Hepatic infarction during pregnancy complicated by antiphospholipid syn drome. Amer J Obstet Gynecol 1993; 169: 199— 202.

199.Young N, Wong KP. Antibody to cardi olipin causing hepatic infarction in a postpartum patient with systemic lupus erythematosus. Aus Radiol 1991; 35: 83—85.

200.Saeki R, Kaneko S, Terasaki S, et al. Mixed types of chronic active hepatitis and pri mary biliary cirrhosis associated with the antiphospholipid antibody syndrome. Hepatogastroenterol 1993; 40: 499—501.

201.Beales ILP. An acquired pseudo Bernard Soulier syndrome occurring with autoimmune chronic active hepatitis and anticardiolipin anti body. Postgrad Med J 1994; 70: 305—308.

202.Kesler A, Pomeranz IS, Huberman H, Movis B, Kott E. Cerebral venous thrombosis and chronic active hepatitis as part of the antiphos pholipid antibody syndrome. Postgrad Med J 1996; 72: 690—692.

203.Cappell M. Oesophageal necrosis and per foration associated with the anticardiolipin anti body syndrome. Am J Gastroenterol 1994; 89: 1241—1245.

204.Kalman DR, Khan A, Ramain PL, Nompleggi DJ. Giant gastric ulceration associat ed with antiphospholipid antibody syndrome. Am J Gastroenterol 1996; 91: 1244—1247.

205.Asherson RA, Morgan S, Harris EN, et al. Arterial occlusion causing large bowel infarction: A reflection of clotting diathesis in SLE. Clin Rheumatol 1986; 5: 102—106.

206.Asherson RA, Mackworth Young C, Harris EN, et al. Multiple venous and arterial thromboses associated with the lupus anticoagu lant and antibodies to cardiolipin in the absence of SLE. Rheumatol Int 1985; 5: 90—93.

207.Sanchez Guerrero J, Reyes E, Alarcon Segovia D. Primary antiphospholipid syndrome as a cause of intestinal infarction. J Rheumatol 1992 19: 623—625.

208.Hamilton ME. Superior mesenteric artery thrombosis associated with antiphospholipid syn drome. West J Med 1991; 155: 174—176.

209.Blanc P, Barki J, Fabre J M, Larrey D, Domergue J, Michel M, Lavabar Bertrand T. Superior mesenteric vein thrombosis associated

with anticardiolipin antibody without autoim mune disease. J Lab Invest 1995; 72: 137.

210.England RJA, Woodcock B, Zeiderman MR. Superior mesenteric artery thrombosis in a patient with the antiphospholipid syndrome. Eur J Vasc Endovasc Surg 1995; 10: 372—373.

211.Vahl AC, Gans ROB, Mackaay AJC, Van Der Waal C, Mauwerda JA. Superior mesenteric artery occlusion and peripheral emboli caused by an aortic ulcer in a young patient with antiphos pholipid syndrome. Surg 1997; 121: 588—590.

212.Cappell MS, Mikhail N, Gujral N. Gastro intestinal haemorrhage and intestinal ischaemia associated with anticardiolipin antibodies. Dig Dis Sciences 1994; 39: 1359—1364.

213.Date K, Shirai Y, Hatakeyama K. Antiphospholipid antibody syndrome presenting as acute acalculous cholecystitis. Am J Gastroenterol 1997: 2127—2128.

214.Arnold MH, Schreiber L. Splenic and renal infarction in systemic lupus eythematosus: Association with anticardiolipin antibodies. Clin Rheumatol 1988; 7: 406—410.

215.Pettersson T, Julkunen H. Asplenia in a patient with systemic lupus erythematosus and antiphospholipid antibodies. J Rheumatol 1992;

19:115.

216.Frances C, Piette J C. Cutaneous man ifestations of Hughes syndrome in the contex of lupus erythematosus. Lupus 1997; 6: 139— 144.

217.Kleiner RC, Najarian IV, Schatten S, et al. Vaso occlusive retinopathy associated with antiphospholipid antibodies (lupus anticoagu lant retinopathy). Ophthalmology 1989; 96: 896—904.

218.Frances C, Tribout B, Boisnic S, et al. Cutaneous necrosis associated with the lupus anticoagulant. Dermatologica 1989; 178: 194— 201.

219.Dessein PH, Lamparelli RD, Phillips SA, Rubenchik IA, Zwi S. Severe immune thrombocy topenia and the development of skin infarctions in a patient with an overlap syndrome. J Rheumatol 1989; 16: 1494—1496.

220.Dodd HJ, Sarkany I, O'Shaughnessy D. Widespread cutaneous necrosis associated with the lupus anticoagulant. Clin Exp Dermatol 1985;

10:581—586.

Насонов Е.Л. Антифосфолипидный синдром

221.Aronoff DM, Callen JP. Necrosing livedo reticularis in a patient with recurrent pulmonary haemorrhage. J Am Acad Dermatol 1997; 37: 300—302.

222.Soweid M, Hajjar RR, Hewan Low KO, Gonzalez EB. Skin necrosis indicating antiphos pholipid syndrome in a patient with AIDS. South Med J 1995; 88: 786—788.

223.Del Castillo LF, Soria C, Schoendorff C, et al. Widespread cutaneous necrosis and antiphospholipid antibodies: Two episodes relat ed to surgical manipulation and urinary tract infection. J Am Acad Dermatol 1997; 36: 872— 875.

224.Amster MS, Conway J, Zeid M, et al. Cutaneous necrosis resulting in protein S defi ciency and increased antiphospholipid antibody in a patient with systemic lupus erythematosus. J Am Acad Dermatol 1993; 29: 853—857.

225.Wolf P, Soyer P, Auer Grumbach P, et al. Widespread cutaneous necrosis in a patient with rheumatoid arthritis associated with anticardi olipin antibodies. Arch Dermatol 1991; 127: 1739—1740.

226.Hill VA, Whittaker SJ, Hunt BJ, et al. Cutaneous necrosis associated with the antiphos pholipid syndrome and mycosis fungoides. Br J Dermatol 1994; 130: 92—96.

227.Doff HJ, Sarkany I, O'Shaughnessy D. Widespread cutaneous necrosis associated with the lupus anticoagulant. Clin Exp Dermatol 1985;

10:581—586.

228.Wattiaux H J, Herve R, Robert A, Cabane J, Housset B, Imbert J C. Coumarin induced skin necrosis associated with acquired protein S deficiency and antiphospholipid anti body syndrome. Arthritis Rheum 1994; 37: 1096—1100.

229.Asherson RA, Jacobelli S, Rosenberg H, et al. Skin nodules and macules resembling vasculi tis in the antiphospholipid syndrome. Clin Exp Dermatol 1992; 17: 166—169.

230.Renfro L, Franks AG, Grudberg M, Kamino H. Painful nodules in a young female — Antiphospholipid syndrome. (Technical Note). Arch Dermat 1992; 128: 847.

231.Asherson RA. Subungual splinter haemor rhages: a new sign of the antiphospholipid coagu lopathy? Ann Rheum Dis 1990; 49: 268.

232.Frances C, Piette J, Saada V, et. al. Mul tiple subungual splinter haemorrhages in the antiphospholipid syndrome. A report of 5 cases and review of the literature. Lupus 1994; 30: 123—128.

233.Kleiner RC, Najarian IV, Schatten S, et al. Vaso occlusive retinopathy associated with antiphospholipid antibodies (lupus anticoagulant retinopathy). Ophthalmology 1989; 96: 896— 904.

234.Digre KB, Durcan FJ, Branch DW, Jacobson DM, Varner MW, Baringer JR. Amaurosis fugax associated with antiphospholipid antibodies. Ann Neurol 1989; 25: 228—232.

235.Carbone J, Sanchez Ramon S, Cobo Soriano R, et al. Antiphospholipid antibodies: A risk factor for occlusive retinal vascular disorders. Comparison with ocular inflammatory diseases. J Rheumatol 2001; 28: 2437.

236.Liote F, Meyer O, Osteoarticular manifes tations in the antiphospholipid syndrome. In: Asherson R A, Cervera R, Piette J C, Shoenfeld Y (Eds). The antiphospholipid syndrome. CRC Press. Boca Raton 1996; 195—200.

237.Klippel TM, Stevens MB, Zizic TM, Hun gerford DS. Ischemic necrosis of bone in systemic lupus erythematosus. Medicine (Baltimore) 1976;

55:251—257.

238.Glueck CJ, Freiberg R, Glueck HE, et al. Hypofibrinolisis: a common, major cause of osteonecrosis. Am J Mematol 1994; 45: 156— 166.

239.Asherson RA, Jungers P, Liot F, et al. Ischaemic necrosis of bone associated with the "lupus anticoagulant" and antibodies to cardi olipin. Proceedings of the XVIth International Congress of Rheumatology. Sydney, Australia. 1983; 373.

240.Asherson RA, Liot F, Page B, et al. Avas cular necrosis of bone and antiphospholipid anti bodies in systemic lupus erythematosus. J Rheumatol 1993; 20: 284—288.

241.Seleznick MJ, Silveira LH, Espinoza LR. Avascular necrosis associated with anticardi olipin antibodies. J Rheumatol 1991; 18: 1416— 1417.

242.Alijotas J, Argem M, Barquinero J. Kienbock's disease and antiphospholipid antibod ies. Clin Exp Rheumatol 1990; 8 297—298.

243.Picillo U, Migliaresi S, Marciolis MR, Longobardo A, La Palombara F, Tirri G. Longi tudinal survey of anticardiolipin antibodies in systemic lupus erythematosus. Relationship with clinical manifestations and disease activity in an Italian series. Scand J Rheumatol 1992; 21: 271—276.

244.Petri M. Musculoskeletal complication of systemic lupus erythematosus in the Hopkins Lupus Cohort: an update. Arthritis Care Res 1995; 18: 137—145.

245.Houissau FA, N'Zeusseu Toukap A, Depresseu XG, et al. Magnetic resonance imag ing detected, avascular necrosis in systemic lupus erythematosus: lack of correlation with antiphos pholipid antibodies. Br J Rheumatol 1998; 37: 448—453.

246.Nagasawa K, Ishii Y, Mayumi T et al. Avascular necrosis of bone in systemic lupus erythematosus: possible role of haemostatic abnormalities. Ann Rheum Dis 1989; 48: 672— 676.

247.Mont MA, Glueck CJ, Pacheco IH, Wang P, Hungerford DS, Petri M. Risk factors for osteonecrosis in systemic lupus erythematosus. J Rheumatol 1997; 24: 654—662.

248.Jones LC, Mont MA, Lr TB, et al. Proco agulants and osteonecrosis. J Rheumatology 2003; 30: 783—791.

249.Tektonidou MG, Malagari K, Vlachoyian nopoulos PG, et al. Asympomatic avascular necrosis in patients with primary antiphospholipid syndrome in the absence of corticosteroid use. Arthritis Rheum 2003; 48: 732—736.

250.Lockwood CJ, Schur PH. Clinical mani festations and diagnosis of the antiphospholipid antibody syndrome in pregnancy. UpToDate 2002; 11.1.

251.Infante Rivard C, David M, Gauthier R, Rivard GE. Lupus anticoagulants, anticardiolipin antibodies, and fetal loss. N Engl J Med 1991;

325:1063.

252.Oshiro BT, Silver RM, Scott JR, et al. Antiphospholipid antibodies and fetal death. Obstet Gynecol 1996; 87: 489.

253.Hornstein MD, Davis OK, Massey JB, et al. Antiphospholipid antibodies and in vitro fertil ization success: a meta analysis. Fertil Steril 2000; 73: 330.

254.Vivaldi P, Rossetti G, Galli M, Finazzi G. Severe bleeding due to acquired hypoprothrom binemia lupus anticoagulant syndrome. Case report and review of literature. Haematologica 1997; 82: 345.

255.Erkan D, Bateman H, Lockshin MD. Lu pus anticoagulant hypoprothrombinemia syn drome associated with systemic lupus erythemato sus: report of 2 cases and review of literature. Lupus 1999; 8: 560.

256.McNeil HP, Chesterman CN, Krilis SA. Immunology and clinical importance of anti phospholipid antibodies. Adv Immunol 1991; 49:193.

257.Harris EN, Gharavi AE, Hegde U, et al. Anticardiolipin antibodies in autoimmune throm bocytopenic purpura. Br J Haematol 1985; 59: 231.

258.Diz Kucukkaya R, Hacihanefioglu A, Yenerel M, et al. Antiphospholipid antibodies and antiphospholipd syndrome in patients pre senting with immune thrombocytopenic purpura: A prospective cohort study. Blood 2001; 98: 1760.

259.Lee T, von Scheven E, Sandborg C. Syste mic lupus erythematosus and antiphospholipid syndrome in children and adolescent. Curr Opin Rheumatol 2001; 13: 415—421.

260.Насонов ЕЛ, Рябова ТВ, Шпитонкова ОЛ, Александрова ЕН. Антифосфолипидный синдром в педиатрии. Детская ревматология 1995; 1: 67—73.

261.Ravelli A, Caporali R, Di Fuccia G, et al. Anticardiolipin antibodies in pediatric systemic lupus erythematosus. Arch Pediatr Adolesc Med 1994; 148: 398—402.

262.Seaman DE, Londjino AV, Jr, Kwoh CK, et al. Antiphospholipid antibodies in pediatric sys temic lupus erythematosus. Pediatrics 1995; 96: 1040—1045.

263.Gattorno M, Buoncompagni A, Molinari AC, et al. Antiphospholipid antibodies in paedi atric systemic lupus eruthematosus, juvenile chronic arthritis and overlap syndromes: SLE patients wuth both lupus anticoagulant and high titre anicardiolipin antibodies are at risk for clinical manifestations related to the antiphospholipid syndrome. Br J Rheumatol 1995; 34: 873—881.

264.Shergy WJ, Kredich DW, Pisetsky DS. The relationship of anticardiolipin antibodies to disease manifwestations in pediatric systemic lupus erythematosus. J Rheumatol 1988; 15: 1389—1394.

265.Berube C, Mitchell L, Silverman E, et al. The relationship of anticardiolipin antibodies to thromboembolic events in pediatriv patients with systemic lupus erythematosus: a cross sectional study. Pediatr Res 1998; 44: 351—358.

266.von Scheven EY, Glidden DV, Elder ME. Anti β2 glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospho lipid syndrome Arthritis Rheum (Arthritis Care Res) 2002; 47: 414—420.

267.Falcini F, Tacetti G, Trapani S, et al. Primary antiphospholipid syndromeL a report of two pediatric cases. J Rheumatology 1991; 18: 1085—1087.

268.Von Landenberg P, Lehmann HW, Knoll A, et al. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection. Arthritis Rheum 2003; 48: 1939—1947.

269.Shpitonkova OV, Ryabova TV, Alexan drova EN, Nasonov EL. Antiphospholipid syn drome (APS) in children with SLE. III European Conference on Systemic Lupus Erythematosus, 1996, Pisa, Italy, 47 (126 abst).

270.Chang D M, Chang C C, Kuo S Y, Chu S J, Chang M L. Hormonal profiles and immunological studies of male lupus in Taiwan. Clin Rheum 1999; 18: 158—162.

271.Folomeev M, Afanasjev W, Alekberova Z. Survival prognostic factors revealed from initial features of systemic lupus erythematosus in male patients. III Intern. Conference on SLE, London, Lupus 1992; 1 (Suppl 1): 122 (аbst).

272.Masi AT, Kaslow RA. Sex effects in sys temic lupus erythematosus: a clue to pathogenesis. Arthr Rheum 1978; 21: 480—484.

273.Kaufman LD, Gomez Reino JJ, Heinicke MH, Gorevic P.D. Male lupus: retro spective analysis of the clinical and laboratory features of 52 patients, with review of the liter ature. Sem Arthr Rheum 1989; 18, 3, 189— 197.

274.Koh WH, Fong KY, Boey ML, Feng PH. Systemic lupus etythematosus in 61 orien

tal males. A study of clinical and laboratory manifestations. Br J Rheum 1994; 33, 339— 342.

275.Miller MH, Urowitz MB, Gladman D.D., Killinger D.W. Systemic lupus erythematosus in males. Medicine (Baltimore) 1983; 62, 5, 327— 334.

276.Sthoeger ZM, Geltner D, Rider A, Bent wich Z. Systemic lupus erythematosus in 49 Israel males: a retrospective study. Clin Exp Rheum 1987; 5: 233—240.

277.Alarcon Segovia D. Antiphospholipid syn drome in SLE. Lupus 1992; 1, (Suppl 1): 13 (abst).

278.Насонов ЕЛ, Алекберова ЗС, Клюквина НГ, Александрова ЕН, Саложин КВ, Ле Тон гез М, Юну П. Антифосфолипидный синдром при системной красной волчанке у мужчин. Клин. медицина, 1996; 4: 18—22.

279.Asherson RA. The "primary" antiphospho lipid syndrome. J Rheumatol 1988; 15: 742— 1746.

280.Alarcon Segovia D, Sanchez Guerrero J. Primary antiphospholipid syndrome J Rheumatol 1989; 16: 482—488.

281.Mackworth Young CG, Loizou S, Walport MJ. Primary antiphospholipid syn drome: features with raised anticardiolipin anti bodies and other disorders. Ann Rheum Dis 1989; 48: 362—367.

282.Mujic F, Cuadrado MJ, Lloyd M, et al. Primary antiphospholipid antibody syndrome evolving into systemic lupus erythematosus. J Rheumatol 1995; 22: 1589.

283.Sneddon IB. Cerebrovascular lesions and livedo reticularis. Br J Dermatol 1965; 77: 180— 185.

284.Kalashnikova LA, Nasonov E.L, Kushekbaeva AE, Gracheva LA. Anticardiolipin antibodies in Sneddon`s syndrome. Neurology 1990; 40: 464—467.

285.Kalashnikova LA, Nasonov EL, Stoyano vich LZ, et al. Sneddon`s syndrome and the pri mary antiphospholipid syndrome. Cerebrovas cular Dis 1994; 4: 76—82.

286.Kalashnikova LA, Nasonov EL, Borisenko VV, et al. Sneddon`s synrome: cardiac pathology and antiphospholipid antibodies. Clin Exp Rheumatol 1991; 9: 357—361.

287.Asherson R.A. The catastrophic antiphospho lipid syndrome J Rheumatol 1992; 19: 508—512.

288.Asherson RA, Cervera R, Font J. Multio rgan thrombotic disorders in systemic lupus erythe matosus: a common link? Lupus 1992; 1: 199 203.

289.Harris EN, Bos K. An acute disseminated coagulopathy vascolopsathy with the antiphos pholipid syndrome. Arch Int Med 1991; 151: 231—233.

290.Ingram SB, Goodnight SH, Bennet RM. An unusual syndrome of devasting non inflam matory vasculopathy associated with anticardi olipin antibodies a report of two cases Arthr Rheum 1987; 30: 1167—1171.

291.Piette JC, Cervera R, Levy RA, Nasonov EL, Shoenfeld Y. The catastrophic Antiphosp holipid syndrome — Asherson`s syndrome. Ann Med Intern 2003.